According to CSCI's research report, the A-share market is currently witnessing escalating structural differentiation, fueled by macroeconomic structural shifts and external marginal pressures. Consequently, the market is anticipated to struggle in breaking the current pattern via a 'high-to-low' strategy, rendering new tracks as the decisive factor in shaping the market's future trajectory. Additionally, mid-year report previews underscore the same pattern of structural differentiation, with new tracks generally performing robustly, whereas traditional tracks lag behind. In terms of market trends, the upward momentum of index fluctuations remains intact, and new tracks have demonstrated a robust ability to attract capital, propelling the market to further heights. Short-term adjustments present investors with prime deployment opportunities. Regarding industry allocation, the convergence of policy support, technological advancements, and demand growth will propel the 'new smart medicine' sector (encompassing new consumption, humanoid robots, artificial intelligence, and innovative drugs) towards sustained prosperity. Meanwhile, dividend-paying sectors can serve as supplementary configurations for managing volatility and hedging risks.